- ADJUNCT ASSISTANT PROFESSOR Oncological Sciences
HIV infection, smoking, prostate cancerMeredith Smith, Ph.D.'s current research portfolio has three main foci:
\r\n(1) Empowering breast cancer and HIV-infected patients to take a more active role in the treatment of their pain by teaching them how to communicate their pain-related symptoms to their physician;
(2) Examining the impact of an expressive writing intervention on immune functioning, clinical health, and psychological adjustment in prostate cancer and HIV-infected patients; and
(3) Promoting physician adherence to smoking cessation guidelines via the use of tailored, computerized feedback about their patients' level of readiness to quit smoking.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Smith is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.
Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.
Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.